Parkinson's disease (PD) is the second most common neurodegenerative disorder, primarily characterized by motor dysfunction.
Grifols, a global healthcare company and leading producer of plasma-derived medicines, today announced it has received a grant from The Michael J. Fox Foundation for Parkinson’s Research (MJFF) to ...
Teams within the Scientific Tracks will join the ASAP CRN, an international, multidisciplinary, and multi-institutional network of collaborating investigators working to address high-priority research ...
There may be a link between hearing impairment and an increased risk of developing Parkinson's according to new research. This is one of the first studies to examine whether sensory impairments, such ...
A new study has identified a potential link between hearing impairment and an increased risk of developing Parkinson’s disease.
Treatment with an oral allosteric modulator was nonsuperior to placebo at 6 weeks in adults with Parkinson’s disease whose ...
Berlin, Germany, and Research Triangle Park, N.C., USA, Jan. 14, 2025 (GLOBE NEWSWIRE) -- Not intended for UK MediaEnrollment ongoing in the ...
Sleep disturbances encompass a broad range of disorders, such as insomnia, restless legs syndrome, parasomnias, sleep-disordered breathing, daytime ...
Regeneron Pharmaceuticals (NASDAQ:REGN) said it currently expects that its financial results for the fourth quarter 2024 will ...
Parkinson's disease is a solvable problem, but only if we act decisively and urgently. We have the knowledge, and we've built ...
A new study has identified polyphosphate as a likely "mystery density" within fibrils associated with Alzheimer's and other ...
Learn how caffeine affects Parkinson's disease prevention and treatment. New research uncovers both protective benefits and treatment limitations.